Boothbay Fund Management LLC Buys 319,984 Shares of Albertsons Companies, Inc. $ACI

Boothbay Fund Management LLC grew its stake in shares of Albertsons Companies, Inc. (NYSE:ACI) by 339.3% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 414,292 shares of the company’s stock after purchasing an additional 319,984 shares during the quarter. Boothbay Fund Management LLC owned about 0.07% of Albertsons Companies worth $8,911,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the stock. Peddock Capital Advisors LLC increased its holdings in Albertsons Companies by 1.9% during the second quarter. Peddock Capital Advisors LLC now owns 26,567 shares of the company’s stock worth $571,000 after buying an additional 504 shares during the last quarter. Mason Investment Advisory Services Inc. grew its position in shares of Albertsons Companies by 0.7% in the 2nd quarter. Mason Investment Advisory Services Inc. now owns 78,586 shares of the company’s stock valued at $1,690,000 after acquiring an additional 524 shares during the period. ProShare Advisors LLC increased its stake in shares of Albertsons Companies by 3.4% during the 2nd quarter. ProShare Advisors LLC now owns 17,870 shares of the company’s stock worth $384,000 after purchasing an additional 592 shares during the last quarter. Verdence Capital Advisors LLC raised its holdings in shares of Albertsons Companies by 0.8% in the 2nd quarter. Verdence Capital Advisors LLC now owns 83,260 shares of the company’s stock valued at $1,791,000 after purchasing an additional 623 shares during the period. Finally, Fifth Third Bancorp raised its holdings in shares of Albertsons Companies by 20.9% in the 2nd quarter. Fifth Third Bancorp now owns 3,624 shares of the company’s stock valued at $78,000 after purchasing an additional 627 shares during the period. Institutional investors and hedge funds own 71.35% of the company’s stock.

Insider Activity at Albertsons Companies

In other news, EVP Michael T. Theilmann sold 100,000 shares of the company’s stock in a transaction that occurred on Thursday, October 16th. The shares were sold at an average price of $19.35, for a total transaction of $1,935,000.00. Following the completion of the sale, the executive vice president owned 338,429 shares of the company’s stock, valued at approximately $6,548,601.15. This represents a 22.81% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Anuj Dhanda sold 230,000 shares of the stock in a transaction that occurred on Thursday, October 16th. The stock was sold at an average price of $19.25, for a total transaction of $4,427,500.00. Following the sale, the insider owned 300,577 shares in the company, valued at $5,786,107.25. This represents a 43.35% decrease in their position. The disclosure for this sale is available in the SEC filing. 1.35% of the stock is currently owned by insiders.

Albertsons Companies Price Performance

Shares of NYSE ACI opened at $17.35 on Friday. The business has a fifty day moving average price of $17.98 and a two-hundred day moving average price of $19.35. The stock has a market capitalization of $9.53 billion, a PE ratio of 10.26, a P/E/G ratio of 2.82 and a beta of 0.49. The company has a debt-to-equity ratio of 2.25, a current ratio of 0.81 and a quick ratio of 0.20. Albertsons Companies, Inc. has a fifty-two week low of $16.70 and a fifty-two week high of $23.20.

Albertsons Companies (NYSE:ACI) last released its earnings results on Tuesday, October 14th. The company reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.04. Albertsons Companies had a return on equity of 36.39% and a net margin of 1.20%.The company had revenue of $18.92 billion for the quarter, compared to analyst estimates of $18.89 billion. During the same period in the prior year, the firm posted $0.51 EPS. Albertsons Companies’s quarterly revenue was up 2.0% on a year-over-year basis. Albertsons Companies has set its FY 2025 guidance at 2.060-2.190 EPS. As a group, equities analysts predict that Albertsons Companies, Inc. will post 2.14 earnings per share for the current fiscal year.

Albertsons Companies Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, November 7th. Shareholders of record on Friday, October 24th were issued a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 3.5%. The ex-dividend date of this dividend was Friday, October 24th. Albertsons Companies’s dividend payout ratio (DPR) is currently 35.50%.

Wall Street Analysts Forecast Growth

ACI has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. lowered their price target on Albertsons Companies from $27.00 to $24.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 8th. Royal Bank Of Canada reduced their target price on Albertsons Companies from $23.00 to $21.00 and set an “outperform” rating for the company in a research note on Friday, October 3rd. UBS Group dropped their price target on Albertsons Companies from $27.00 to $25.00 and set a “buy” rating on the stock in a research note on Wednesday, October 15th. Bank of America cut their price target on Albertsons Companies from $24.00 to $22.00 and set a “neutral” rating for the company in a report on Wednesday, October 15th. Finally, Wall Street Zen downgraded shares of Albertsons Companies from a “buy” rating to a “hold” rating in a report on Sunday, November 2nd. Ten analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $23.77.

About Albertsons Companies

Albertsons Companies, Inc, through its subsidiaries, engages in the operation of food and drug stores in the United States. The company’s food and drug retail stores offer grocery products, general merchandise, health and beauty care products, pharmacy, fuel, and other items and services. It also manufactures and processes food products for sale in stores.